• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Not Just Another Reporting Guideline? Here's Why READUS-PV is a Major Step Forward.

作者信息

Loke Yoon K

机构信息

Norwich Medical School, University of East Anglia, Norwich, NR4 7TJ, UK.

出版信息

Drug Saf. 2024 Jun;47(6):571-573. doi: 10.1007/s40264-024-01441-5. Epub 2024 May 8.

DOI:10.1007/s40264-024-01441-5
PMID:38720115
Abstract
摘要

相似文献

1
Not Just Another Reporting Guideline? Here's Why READUS-PV is a Major Step Forward.不仅仅是另一个报告指南？这就是为什么READUS-PV是向前迈出的重要一步。
Drug Saf. 2024 Jun;47(6):571-573. doi: 10.1007/s40264-024-01441-5. Epub 2024 May 8.
2
The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration.《使用药物警戒中的个体病例安全报告进行药物安全性信号检测的不适当性分析报告（READUS-PV）：解释与说明》。
Drug Saf. 2024 Jun;47(6):585-599. doi: 10.1007/s40264-024-01423-7. Epub 2024 May 7.
3
The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement.使用个体病例安全报告在药物警戒中进行药物安全性信号检测的不均衡分析报告：方法学开发与声明。
Drug Saf. 2024 Jun;47(6):575-584. doi: 10.1007/s40264-024-01421-9. Epub 2024 May 7.
4
European Medicines Agency assesses safety reporting at Roche.欧洲药品管理局评估罗氏公司的安全报告。
Lancet Oncol. 2012 Aug;13(8):e331. doi: 10.1016/s1470-2045(12)70297-8.
5
Publishing histories of adverse reactions to medicaments anecdotally: the PHARMA guidelines for reporting suspected adverse drug reactions.药物不良反应轶事性发布历史：疑似药物不良反应报告的PHARMA指南
Drug Saf. 2008;31(4):355-6; author reply 356-7. doi: 10.2165/00002018-200831040-00009.
6
Low quality of reporting adverse drug reactions in paediatric randomised controlled trials.儿科随机对照试验中药物不良反应报告质量低。
Arch Dis Child. 2010 Dec;95(12):1023-6. doi: 10.1136/adc.2009.175562. Epub 2010 Jun 15.
7
Adherence to CONSORT harms-reporting recommendations in publications of recent analgesic clinical trials: an ACTTION systematic review.近期镇痛药临床试验报告中对 CONSORT 损害报告建议的遵循情况：ACTTION 系统评价。
Pain. 2012 Dec;153(12):2415-2421. doi: 10.1016/j.pain.2012.08.009. Epub 2012 Sep 15.
8
Why were NIH adverse event reporting guidelines misunderstood?为什么美国国立卫生研究院的不良事件报告指南会被误解？
J Natl Cancer Inst. 2000 May 17;92(10):784-6. doi: 10.1093/jnci/92.10.784.
9
Mandatory pharmacovigilance.强制性药物警戒
CMAJ. 2003 Mar 18;168(6):672; discussion 672-3.
10
Toward standardized reporting of drug interactions: the READI checklist for anecdotal reports.迈向药物相互作用的标准化报告：轶事报告的READI清单
Expert Rev Clin Pharmacol. 2015;8(4):399-409. doi: 10.1586/17512433.2015.1049598. Epub 2015 May 27.

引用本文的文献

1
Real-World Safety Profile of Proton Pump Inhibitors in Infants as Reported in the FDA Adverse Event Reporting System (FAERS): Tiny Tummies, Key Decisions.美国食品药品监督管理局不良事件报告系统（FAERS）报告的婴儿使用质子泵抑制剂的真实世界安全性概况：小婴儿，关键决策。
Pharmaceuticals (Basel). 2025 May 16;18(5):730. doi: 10.3390/ph18050730.
2
Pregnancy related adverse events and congenital disorders associated with fluoroquinolones: A real-world pharmacovigilance study of the FDA adverse event reporting system (FAERS).与氟喹诺酮类药物相关的妊娠不良事件和先天性疾病：对美国食品药品监督管理局不良事件报告系统（FAERS）的一项真实世界药物警戒研究。
Heliyon. 2024 Sep 7;10(18):e37547. doi: 10.1016/j.heliyon.2024.e37547. eCollection 2024 Sep 30.

本文引用的文献

1
The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration.《使用药物警戒中的个体病例安全报告进行药物安全性信号检测的不适当性分析报告（READUS-PV）：解释与说明》。
Drug Saf. 2024 Jun;47(6):585-599. doi: 10.1007/s40264-024-01423-7. Epub 2024 May 7.
2
New Adverse Drug Reaction Signals from 2017 to 2021-Genuine Alerts or False Alarms?2017年至2021年新的药品不良反应信号——真实警报还是虚惊一场？
Pharmacy (Basel). 2024 Feb 10;12(1):33. doi: 10.3390/pharmacy12010033.
3
Pharmacovigilance studies without a priori hypothesis: systematic review highlights inappropriate multiple testing correction procedures.
无先验假设的药物警戒研究：系统评价凸显不适当的多重检验校正程序
J Clin Epidemiol. 2023 Oct;162:127-134. doi: 10.1016/j.jclinepi.2023.08.010. Epub 2023 Aug 31.
4
A meta-epidemiological study found lack of transparency and poor reporting of disproportionality analyses for signal detection in pharmacovigilance databases.一项荟萃流行病学研究发现，药物警戒数据库中信号检测的不均衡分析缺乏透明度和报告质量较差。
J Clin Epidemiol. 2021 Nov;139:191-198. doi: 10.1016/j.jclinepi.2021.07.014. Epub 2021 Jul 27.
5
High prevalence of spin was found in pharmacovigilance studies using disproportionality analyses to detect safety signals: a meta-epidemiological study.在使用不成比例分析来检测安全信号的药物警戒研究中发现自旋的高患病率：一项元流行病学研究。
J Clin Epidemiol. 2021 Oct;138:73-79. doi: 10.1016/j.jclinepi.2021.06.022. Epub 2021 Jun 26.
6
When to publish measures of disproportionality derived from spontaneous reporting databases?何时公布源自自发报告数据库的不成比例性衡量指标？
Br J Clin Pharmacol. 2011 Dec;72(6):909-11. doi: 10.1111/j.1365-2125.2011.04087.x.
7
Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports.使用比例报告比（PRR）从自发药物不良反应报告中生成信号。
Pharmacoepidemiol Drug Saf. 2001 Oct-Nov;10(6):483-6. doi: 10.1002/pds.677.